These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21205720)

  • 1. Adequate use of pulmonary embolism clinical prediction rule in COPD patients.
    Bertoletti L; Righini M
    Eur Respir J; 2011 Jan; 37(1):219-20; author reply 220-1. PubMed ID: 21205720
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic indices for COPD patient management: how many do we need?
    van Dijk WD; Schermer TR; van Weel C
    Eur Respir J; 2012 Jan; 39(1):223-4. PubMed ID: 22210817
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of cluster analysis to define COPD phenotypes.
    Weatherall M; Shirtcliffe P; Travers J; Beasley R
    Eur Respir J; 2010 Sep; 36(3):472-4. PubMed ID: 20930198
    [No Abstract]   [Full Text] [Related]  

  • 4. Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism.
    Stein PD; Matta F
    Thromb Haemost; 2013 May; 109(5):897-900. PubMed ID: 23467701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboemboli and exacerbations of COPD.
    Gunen H; Gulbas G; In E; Yetkin O; Hacievliyagil SS
    Eur Respir J; 2010 Jun; 35(6):1243-8. PubMed ID: 19926740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational monitoring of COPD: where do current clinical guidelines stand?
    van den Bemt L; Schermer T; van Weel C
    Eur Respir J; 2007 Jun; 29(6):1078-81. PubMed ID: 17540784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Management of COPD by chest physicians in Poland].
    Górecka D; Zieliński J
    Pneumonol Alergol Pol; 2009; 77(6):497-9. PubMed ID: 20013698
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical presentation and outcome of venous thromboembolism in COPD.
    Bertoletti L; Quenet S; Mismetti P; Hernández L; Martín-Villasclaras JJ; Tolosa C; Valdés M; Barrón M; Todolí JA; Monreal M;
    Eur Respir J; 2012 Apr; 39(4):862-8. PubMed ID: 21885395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex chronic comorbidities of COPD.
    Fabbri LM; Luppi F; Beghé B; Rabe KF
    Eur Respir J; 2008 Jan; 31(1):204-12. PubMed ID: 18166598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary thromboembolism, blood gas status and left ventricular function in COPD.
    Jolobe OMP
    Int J Cardiol; 2019 Oct; 292():211. PubMed ID: 31349940
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases.
    Bahloul M; Chaari A; Tounsi A; Baccouche N; Abid H; Chtara K; Ben Hamida C; Ghadhoune H; Dammak H; Chelly H; Bouaziz M
    Clin Respir J; 2015 Jul; 9(3):270-7. PubMed ID: 24612880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Updated guidelines of the Société de Pneumologie de Langue Française for the management of chronic obstructive pulmonary disease: essential points].
    Société de Pneumologie de Langue Française
    Rev Mal Respir; 2003 Apr; 20(2 Pt 1):294-9. PubMed ID: 12844030
    [No Abstract]   [Full Text] [Related]  

  • 13. An "alternative" clinical course of COPD exacerbation and pulmonary embolism.
    Terzano C; Conti V; Petroianni A; Paone G
    Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3341-6. PubMed ID: 24379066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease?
    Rutschmann OT; Cornuz J; Poletti PA; Bridevaux PO; Hugli OW; Qanadli SD; Perrier A
    Thorax; 2007 Feb; 62(2):121-5. PubMed ID: 17101737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations].
    Mispelaere D; Glerant JC; Audebert M; Remond A; Sevestre-Pietri MA; Jounieaux V
    Rev Mal Respir; 2002 Sep; 19(4):415-23. PubMed ID: 12417857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician specialty as a source of heterogeneity in the care of patients with COPD.
    Paladini L; Hodder R; Bellia V; Marchionni N; Di Bari M; Cecchini I; Pistelli R; Antonelli-Incalzi R
    Chest; 2011 Dec; 140(6):1666-1667. PubMed ID: 22147829
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosing acute pulmonary embolism: effect of chronic obstructive pulmonary disease on the performance of D-dimer testing, ventilation/perfusion scintigraphy, spiral computed tomographic angiography, and conventional angiography. ANTELOPE Study Group. Advances in New Technologies Evaluating the Localization of Pulmonary Embolism.
    Hartmann IJ; Hagen PJ; Melissant CF; Postmus PE; Prins MH
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2232-7. PubMed ID: 11112144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LR-PED rule: low risk pulmonary embolism decision rule - a new decision score for low risk pulmonary embolism.
    Barra S; Paiva L; Providência R; Fernandes A; Nascimento J; Marques AL
    Thromb Res; 2012 Sep; 130(3):327-33. PubMed ID: 22465039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does this patient have pulmonary embolism?
    Chunilal SD; Eikelboom JW; Attia J; Miniati M; Panju AA; Simel DL; Ginsberg JS
    JAMA; 2003 Dec; 290(21):2849-58. PubMed ID: 14657070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the pretest probability threshold to justify empiric administration of heparin prior to pulmonary vascular imaging for pulmonary embolism.
    Hogg KE; Brown MD; Kline JA
    Thromb Res; 2006; 118(5):547-53. PubMed ID: 16356538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.